L. Shariati, H. Khanahmad, Mansoor Salehi, Z. Hejazi, I. Rahimmanesh, Mohammad Amin Tabatabaiefar, M. Modarressi
{"title":"使用CRISPR/Cas9系统对KLF1基因进行遗传破坏以过度表达γ -珠蛋白基因","authors":"L. Shariati, H. Khanahmad, Mansoor Salehi, Z. Hejazi, I. Rahimmanesh, Mohammad Amin Tabatabaiefar, M. Modarressi","doi":"10.1002/jgm.2928","DOIUrl":null,"url":null,"abstract":"β‐thalassemia comprises a major group of human genetic disorders involving a decrease in or an end to the normal synthesis of the β‐globin chains of hemoglobin. KLF1 is a key regulatory molecule involved in the γ‐ to β‐globin gene switching process directly inducing the expression of the β‐globin gene and indirectly repressing γ‐globin. The present study aimed to investigate the ability of an engineered CRISPR/Cas9 system with respect to disrupting the KLF1 gene to inhibit the γ‐ to β‐hemoglobin switching process in K562 cells.","PeriodicalId":328333,"journal":{"name":"The Journal of Gene Medicine","volume":"23 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2016-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"38","resultStr":"{\"title\":\"Genetic disruption of the KLF1 gene to overexpress the γ‐globin gene using the CRISPR/Cas9 system\",\"authors\":\"L. Shariati, H. Khanahmad, Mansoor Salehi, Z. Hejazi, I. Rahimmanesh, Mohammad Amin Tabatabaiefar, M. Modarressi\",\"doi\":\"10.1002/jgm.2928\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"β‐thalassemia comprises a major group of human genetic disorders involving a decrease in or an end to the normal synthesis of the β‐globin chains of hemoglobin. KLF1 is a key regulatory molecule involved in the γ‐ to β‐globin gene switching process directly inducing the expression of the β‐globin gene and indirectly repressing γ‐globin. The present study aimed to investigate the ability of an engineered CRISPR/Cas9 system with respect to disrupting the KLF1 gene to inhibit the γ‐ to β‐hemoglobin switching process in K562 cells.\",\"PeriodicalId\":328333,\"journal\":{\"name\":\"The Journal of Gene Medicine\",\"volume\":\"23 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"38\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of Gene Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/jgm.2928\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Gene Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/jgm.2928","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Genetic disruption of the KLF1 gene to overexpress the γ‐globin gene using the CRISPR/Cas9 system
β‐thalassemia comprises a major group of human genetic disorders involving a decrease in or an end to the normal synthesis of the β‐globin chains of hemoglobin. KLF1 is a key regulatory molecule involved in the γ‐ to β‐globin gene switching process directly inducing the expression of the β‐globin gene and indirectly repressing γ‐globin. The present study aimed to investigate the ability of an engineered CRISPR/Cas9 system with respect to disrupting the KLF1 gene to inhibit the γ‐ to β‐hemoglobin switching process in K562 cells.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
